SAN FRANCISCO, Jan 8 – Structural Genomix’ deal to jointly develop a new protein analysis system with Caliper Technologies represents one of two types of transactions the company is looking to forge, Linda Grais, Structural Genomix’ executive vice president and founder, said Monday.

"In some deals, we will be licensing technology in and in others we will sell information about protein structures," said Grais, who was attending the JP Morgan H&Q conference.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.